Abstract
Most pharmacologic and technologic advances over the past decades to address heart failure have focused on the left ventricle, while allowing the right ventricle (RV) to be a passive bystander. However, most surgeons who perform complex cardiovascular surgery with prolonged ischemic times have been humbled time and again by RV dysfunction postcardiotomy. Despite improvements in myocardial protection, RV failure, when it occurs, carries significant morbidity1,2 and is a feared complication after cardiac surgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.